Who has invested in Innogen Pharmaceutical?

No investors are named on the public record for Innogen Pharmaceutical yet.

Innogen Pharmaceutical Funding: $206M Raised, IPO (2025)

Innogen Pharmaceutical funding overview

Innogen Pharmaceutical has raised $206M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in August 2025. The round record for Innogen Pharmaceutical runs through 2025; nothing later has been disclosed.

Innogen Pharmaceutical at a glance

Total raised: $206M
Latest round: IPO
Latest round date: August 2025

Frequently asked about Innogen Pharmaceutical funding

How much has Innogen Pharmaceutical raised?: Innogen Pharmaceutical has raised $206M in total disclosed funding across the rounds on record.
Who has invested in Innogen Pharmaceutical?: No investors are named on the public record for Innogen Pharmaceutical yet.
What was the latest Innogen Pharmaceutical funding round?: The most recent disclosed round is an IPO, announced in August 2025.
Where is Innogen Pharmaceutical based?: No headquarters location is disclosed for Innogen Pharmaceutical.
When did Innogen Pharmaceutical last raise?: The last disclosed Innogen Pharmaceutical round closed in August 2025 at IPO.

Every Innogen Pharmaceutical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies at a similar stage.

Innogen Pharmaceutical Funding: $206M Raised, IPO (2025)

Innogen Pharmaceutical funding overview

Innogen Pharmaceutical at a glance

Frequently asked about Innogen Pharmaceutical funding

Companies related to Innogen Pharmaceutical (30)

Browse related funding lists (3)